Saransh Chaudhary
-
Venus Remedies secures Kenyan GMP Certification for its manufacturing facilities in Baddi
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its…
Read More » -
Venus Remedies bags recognition for in-house R&D excellence
The company invested 3.53 per cent of its total sales in R&D, from which it has generated 5.25 per cent…
Read More » -
Venus Remedies bags marketing approval from the Philippines, Iraq for onco drugs
The company expects marketing authorisation from Iraq for another commonly prescribed cancer drug, gemcitabine, to enhance its reach in MENA region…
Read More » -
Venus Remedies secures marketing authorisation from UK for Cisplatin
The product registration granted to Venus Pharma, the company’s German subsidiary, will enable it to offer its affordable range of…
Read More » -
Venus Remedies joins India AMR Innovation Hub
The company has joined the Convergent Global Think Tank to help develop and implement sustainable solutions for reducing India’s burgeoning…
Read More » -
Post-Budget reaction: Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre (VMRC)
The decision to come up with a new agenda to promote research and innovation in the pharmaceutical space through centres…
Read More » -
Pre-Budget expectations: Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, VMRC
The upcoming Budget should aim at establishing India as the Pharmacy of the World by enhancing the manufacturing and research…
Read More » -
Budget Expectations 2022
Experts put forth their views on the upcoming Budget 2022 Saransh Chaudhary, President, Global Critical Care,…
Read More »